Should prolactin be reconsidered as a therapeutic target in human breast cancer?
about
Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cellsSynergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptorsGrowth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complexThe role of prolactin in mammary carcinoma.Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic miceComplex prolactin crosstalk in breast cancer: new therapeutic implicationsProteasomes mediate prolactin-induced receptor down-regulation and fragment generation in breast cancer cellsHyperprolactinaemia as an adverse effect in regulatory and clinical toxicology: role in breast and prostate cancer.GHR/PRLR Heteromultimer Is Composed of GHR Homodimers and PRLR HomodimersThe role of prolactin receptor in GH signaling in breast cancer cellsExcessive milk production during breast-feeding prior to breast cancer diagnosis is associated with increased risk for early events.Adverse effects of prolactin in rodents and humans: breast and prostate cancer.Analysis of site-specific histidine protonation in human prolactinPreclinical risk assessment of drug-induced hypo- and hyperprolactinemia.Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.Prolactin--to be reconsidered in canine mammary tumourigenesis?Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways.No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.Utilizing the hair follicle to dissect the regulation and autocrine/paracrine activities of prolactin in humans.
P2860
Q24675637-46C9CB53-BFD1-4BCC-9B60-3DA1379034B6Q34519099-24BF6EB0-C41C-4806-AFF7-34D34932DAD5Q34712091-7AFE2C5D-537F-41A8-871A-254D982DE7D0Q35067253-43084C25-9104-4152-B4C3-BA6A2A360FA6Q35121912-C4E8FBFB-7D0A-4FAC-97CA-B00075424DFBQ35303180-16912D7E-A079-4B9A-80A2-757DDBC2F546Q35990940-EDD10932-C335-4367-9DA7-1368D02D8DE0Q36560758-54A80B35-0DF6-4DDF-8717-C6115856FF9FQ36859543-440C48D2-6398-4AB6-85BA-CA9DECEF9E37Q36932552-49172B32-E21E-4D8C-A8DE-ADA2B89F19FEQ36997715-22BF8E33-638B-4450-A626-0DE3E2025A99Q37246047-75E431FE-0ED8-41C9-BA57-5C91BB941AE3Q37397564-DB90A9AB-F47B-403F-84ED-B3336F261418Q37925692-D4C1D813-CC90-476A-9662-B3EE6EC6176EQ37957807-87EEFFF2-4DBD-4E42-AECD-85A1EFDAF4EAQ38022089-9331A009-B7E0-455F-A184-75C1C12776A6Q40265329-9D8748C7-1635-471D-8906-A114AEB73A63Q42290800-B0587EFB-3D38-49E6-83B9-C3EFB9C28A19Q44959701-9CD873DC-7267-4568-8FC7-8A53C5B072BEQ48511056-C5B85F5C-C97A-4CD9-898C-6A4451593BB4
P2860
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@ast
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@en
type
label
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@ast
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@en
prefLabel
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@ast
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@en
P2093
P1476
Should prolactin be reconsidered as a therapeutic target in human breast cancer?
@en
P2093
P356
10.1016/S0303-7207(99)00023-4
P577
1999-05-01T00:00:00Z